Comarch Healthcare S.A.
- Address
- Ul. Prof. Michala Zyczkowskiego 29 A, 31-864 Krakow, Poland
Comarch Healthcare S.A. - Respiratory and Allergic Disease Research Center
Comarch Healthcare S.A. is a specialized clinical research center with demonstrated expertise in respiratory medicine and allergic disorders. The center focuses on conducting complex clinical trials evaluating novel therapeutics and interventional strategies for asthma and related allergic conditions, ranging from early-phase bioequivalence studies to advanced efficacy trials in severe disease populations.
- Eosinophilic asthma and severe asthma exacerbation management
- Allergic rhinoconjunctivitis and immunotherapy optimization
- Oncology research in biochemically recurrent prostate cancer
The center has particular strength in evaluating pulmonary function outcomes and conducting bioequivalence studies for inhalation therapies. With experience across multiple therapeutic areas including respiratory immunology and targeted oncology treatments, Comarch Healthcare demonstrates proficiency in managing diverse patient populations from adolescents to adults, and executing both short-term intervention trials and extended 52-week efficacy studies in severe eosinophilic asthma.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 4 by active trials.
- 1Eikon Therapeutics Inc.1active
lock +3 more on a paid plan
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Areteia Therapeutics Inc.3trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 624 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Comarch Healthcare S.A.
lock Showing 1 of 8 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| (21492 ARASTEP) A randomized, double-blind, placebo-controlled Phase 3 study of darolutamide plus androgen deprivation therapy (ADT) compared with placebo plus ADT in patients with high-risk biochemical recurrence (BCR) of prostate cancer | Bayer AG, Bayer Consumer Care AG | Phase III | Not Recruiting | Oct 2023 | — |
IMP list
lock Showing 1 of 15 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Dexpramipexole Dihydrochloride Monohydrate | 3 | Unknown | 2023-04-25 | 2024-10-14 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.